BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 21898433)

  • 1. Analysis of eIF4E and 4EBP1 mRNAs in head and neck cancer.
    Sunavala-Dossabhoy G; Palaniyandi S; Clark C; Nathan CO; Abreo FW; Caldito G
    Laryngoscope; 2011 Oct; 121(10):2136-41. PubMed ID: 21898433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy.
    Huang CI; Wang CC; Tai TS; Hwang TZ; Yang CC; Hsu CM; Su YC
    PLoS One; 2019; 14(11):e0225537. PubMed ID: 31756179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Over-expressions of p-eIF4E and p-4EBP1 are associated with poor prognosis in nasopharyngeal carcinoma].
    Zheng J; Zhang C; Zhang Y; Pei J; Fan S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Apr; 33(4):531-535. PubMed ID: 28395726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Australian retrospective study to evaluate the prognostic role of p53 and eIF4E cancer markers in patients with head and neck squamous cell carcinoma (HNSCC): study protocol.
    Singh J; Jayaraj R; Baxi S; Mileva M; Curtin J; Thomas M
    Asian Pac J Cancer Prev; 2013; 14(8):4717-21. PubMed ID: 24083732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer.
    Nathan CO; Franklin S; Abreo FW; Nassar R; De Benedetti A; Glass J
    J Clin Oncol; 1999 Sep; 17(9):2909-14. PubMed ID: 10561370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of 4EBP1/eIF4E Activation in Renal Cell Carcinoma Could Differentially Predict Its Early and Late Recurrence.
    Ichiyanagi O; Naito S; Ito H; Kabasawa T; Narisawa T; Kanno H; Kurota Y; Kurokawa M; Fukuhara H; Sakurai T; Nishida H; Kato T; Yamakawa M; Tsuchiya N
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1029-e1058. PubMed ID: 30297141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive amplification and overexpression of the eukaryotic initiation factor 4E gene in different zones of head and neck cancers.
    Sorrells DL; Ghali GE; De Benedetti A; Nathan CO; Li BD
    J Oral Maxillofac Surg; 1999 Mar; 57(3):294-9. PubMed ID: 10077200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
    Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
    Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of Patients With Head and Neck Squamous Cell Carcinoma Can be Predicted by Expression of eIF4E and Osteopontin in Free Surgical Margins.
    Abouhashem NS; Elwan A; Elaidy NF
    Appl Immunohistochem Mol Morphol; 2022 May-Jun 01; 30(5):e40-e49. PubMed ID: 35285458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM2 is overexpressed and regulated by the eukaryotic translation initiation factor 4E (eIF4E) in human squamous cell carcinoma of esophagus.
    Hsu HS; Chen HW; Kao CL; Wu ML; Li AF; Cheng TH
    Ann Surg Oncol; 2011 May; 18(5):1469-77. PubMed ID: 21080085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pattern of amplification and overexpression of the eukaryotic initiation factor 4E gene in solid tumor.
    Sorrells DL; Meschonat C; Black D; Li BD
    J Surg Res; 1999 Jul; 85(1):37-42. PubMed ID: 10383835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of Eukaryotic Initiation Factor 4E (eIF4E) Level among Cases Suffering Basal Cell Carcinoma of Skin.
    Han B; Zhang Q; Li G; Zhang R; Li H
    Med Sci Monit; 2019 Oct; 25():7936-7941. PubMed ID: 31641096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated patients with breast cancer.
    Wolfort R; de Benedetti A; Nuthalapaty S; Yu H; Chu QD; Li BD
    Surgery; 2006 Aug; 140(2):161-9. PubMed ID: 16904965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.
    Vlatković N; El-Fert A; Devling T; Ray-Sinha A; Gore DM; Rubbi CP; Dodson A; Jones AS; Helliwell TR; Jones TM; Boyd MT
    Cancer; 2011 Jul; 117(13):2939-50. PubMed ID: 21692053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival analysis of head and neck squamous cell carcinoma: influence of smoking and drinking.
    Farshadpour F; Kranenborg H; Calkoen EV; Hordijk GJ; Koole R; Slootweg PJ; Terhaard CH
    Head Neck; 2011 Jun; 33(6):817-23. PubMed ID: 20737489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective study of eukaryotic initiation factor 4E protein elevation and breast cancer outcome.
    Li BD; Gruner JS; Abreo F; Johnson LW; Yu H; Nawas S; McDonald JC; DeBenedetti A
    Ann Surg; 2002 May; 235(5):732-8; discussion 738-9. PubMed ID: 11981220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
    Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
    Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological tailoring of adjuvant radiotherapy in head and neck and oral malignancies - The potential role of p53 and eIF4E as predictive parameters.
    Joseph B; Kumar RV; Champaka G; Shenoy A; Sabitha KS; Lokesh V; Ramesh C; Vijay CR
    Indian J Cancer; 2019; 56(4):330-334. PubMed ID: 31607702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
    Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
    J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.
    Wang Z; Feng X; Molinolo AA; Martin D; Vitale-Cross L; Nohata N; Ando M; Wahba A; Amornphimoltham P; Wu X; Gilardi M; Allevato M; Wu V; Steffen DJ; Tofilon P; Sonenberg N; Califano J; Chen Q; Lippman SM; Gutkind JS
    Cancer Res; 2019 Apr; 79(7):1438-1450. PubMed ID: 30894372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.